Literature DB >> 24625858

Vernet's syndrome after carotid endarterectomy.

Tomonori Tamaki1, Yoji Node, Norihiro Saitoum, Hideto Saigusa, Michio Yamazaki, Akio Morita.   

Abstract

Unilateral paresis of cranial nerves IX to XI is defined as Vernet's syndrome. We retrospectively assessed cranial nerve symptoms from the clinical records of 143 carotid endarterectomy patients. A flexible nasolaryngoscope was used to examine vocal fold movements in 73 patients. If vocal fold paresis (VFP) was confirmed, the patient also underwent magnifying laryngoscopy (for correct diagnosis of injury to the glossopharyngeal and vagus nerves). It was found from clinical records that 8 patients (6%) were confirmed to have cranial nerve symptoms corresponding to Vernet's syndrome; 7 patients (9 %) had VFP on nasolaryngoscopy. In 2 patients, magnifying laryngoscopy confirmed ipsilateral VFP, pharyngeal paresis, pharyngeal wall hypesthesia, and ipsilateral pharyngeal wall swelling. These 2 patients also had symptoms of injury to the accessory nerve. Damage to cranial nerves IX to XI probably occurred in the parapharyngeal space, based on the existence of posterior pharyngeal wall edema or swelling after carotid endarterectomy.

Entities:  

Keywords:  carotid endarterectomy; cranial nerve; hoarseness; parapharyngeal space; vagus nerve

Mesh:

Year:  2013        PMID: 24625858     DOI: 10.1177/1531003514525476

Source DB:  PubMed          Journal:  Perspect Vasc Surg Endovasc Ther        ISSN: 1521-5768


  2 in total

Review 1.  Lower cranial nerve syndromes: a review.

Authors:  Santiago Gutierrez; Tyler Warner; Erin McCormack; Cassidy Werner; Mansour Mathkour; Joe Iwanaga; Aysun Uz; Aaron S Dumont; R Shane Tubbs
Journal:  Neurosurg Rev       Date:  2020-07-08       Impact factor: 3.042

2.  Posttraumatic Vernet syndrome without fracture: A case report and short literature review.

Authors:  Tamara Braut; Matej Maršić; Iva Ravlić; Diana Maržić; Blažen Marijić; Goran Malvić; Ilinko Vrebac; Marko Velepič
Journal:  Medicine (Baltimore)       Date:  2021-10-29       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.